Delighted to announce that today I joined the fantastic team @MTWnhs as a Consultant Colorectal & General Surgeon! Excited to get started at what is a very exciting time for our department, and overwhelmed by the support from my new colleagues across the board. Here’s to 2024!
Hypermutator cancers are defined by increased mutation rates.
But do mutation rates evolve with time during tumour growth?⏱️
In this work @NatureGenet we show that hypermutator cancers use an unexpected set of genetic gear switches to adapt mutation rates to immune selection.
How do mismatch repair-deficient (MMRd) cancers trade off the evolutionary costs and benefits of elevated mutation rates?
Delighted to share our paper on adaptive mutability in MMRd colorectal cancer (CRC) @NatureGenetnature.com/articles/s41588-0…
Tweetorial 🧵below
Really exciting news this morning that my oncology colleague Dr Vicky Kunene @uhbtrust dosed the first patient in the BioNTech BNT-122 mRNA vaccine trial for personalised therapy in colorectal cancer - @UHBResearch was the first site in UK to do this:
bbc.co.uk/news/articles/cl77…
Totally agree. The days of taking someone off to theatre for complications of a hernia or severe abdo pain with no imaging are largely over. We need to be armed with as much info as we can safely obtain to deliver the best outcomes. Rarely that balance will mean an immediate op.
Surgery for advanced neuroendocrine tumours of the small bowel: recommendations based on a consensus meeting of the European Society of Endocrine Surgeons (ESES)
➡️doi.org/10.1093/bjs/znae082
This paper provides evidence-based recommendations on the surgical management of locally advanced and metastatic small bowel neuroendocrine tumours, primary tumour resections in the setting of metastatic disease, and surgical indications for grade 3 small bowel neuroendocrine tumours and small bowel neuroendocrine carcinomas.
The recommendations are the result of a working group of experts, created by the European Society of Endocrine Surgeons. The group addressed 11 relevant clinical questions regarding surgery for advanced disease, emphasizing and confirming the key role of the surgeon for advanced small bowel neuroendocrine tumours.
Great work by Klaas Van Den Heede, Dirk-Jan van Beek, Sam Van Slycke, Inne Borel Rinkes, Olov Norlén, Peter Stålberg, Erik Nordenström
#SoMe4Surgery#MedTwitter#SurgEd#Surgery @RCPSGTrainees @aecirujanos@SEIQuirurgica@iss_sic#MedicalTechniques@BJSAcademy@young_bjs@BJSOpen@des_winter@evanscolorectal@robhinchliffe1@bplwijn@ksoreide@MalinASund@nfmkok@TejedorPat@paulo_sutt@PVaughanShaw@JJEarnshaw@juliomayol#endocrine@IfsoSecretariat
Important secondary analysis of the OPRA trial with a median f/u of 4 years.
This provides important details from a landmark study, and can help guide patient counseling. Of note, it's not broken down to compare induction TNT to consolidation TNT.
My analysis is long-winded, and the target audience is surgeons who offer organ preservation to patients with rectal cancer:
Patients with a cCR at restaging: 98% offered organ preservation/watch-and-wait (WW), of which 22% experienced local regrowth. Patients with a sustained cCR had a 5% rate of distant metastases.
Of the local regrowths, 93% underwent salvage TME and 7% underwent salvage local excision. For these patients, 33% developed recurrence (4% local, 22% distant, and 7% local+distant).
_______________________________________
Patients with a near-complete CR at restaging: 20 (17.5%) went straight to surgery, of which only 3 (16%) had a pathologic CR (pCR). Recurrence after upfront TME for near-cCR was 30% (15% local, 10% distant, 5% local+distant). These numbers were small (n=3 for local recurrence) and should be interpreted with caution.
Of the remaining 94 patients (82.5%) who underwent WW, 48 (51%) developed local regrowth. Salvage TME was performed in 34 patients (71% compared to 93% for cCRs). 2 of 34 TMEs (6%) had a pCR.
For patients with a near-cCR who developed regrowth after WW, 33% developed recurrence (4% local, 21% distant, 8% local+distant).
Of the 46 patients (40%) with a near-cCR who remained in the WW program, 13% developed distant metastases (compared to 5% for cCRs).
______________________________________
Patients with an incomplete response at restaging:
88% were offered upfront TME, of which 4/51 (8%) had a pCR. For ICR and upfront TME, recurrence rate was 35% (3.5% local, 21% distant, 10.5% local+distant).
8 patients with incomplete response were still enrolled in WW for different reasons, of which 5/8 (63%) developed local regrowth. All 5 underwent TME, and the local recurrence was 20% (1/5). Of the 3/8 that remained in WW without regrowth, 2/3 (66%) developed lung metastases.
_______________________________________
Overall, the 3-year organ preservation rate was 77% for cCRs and 40% for near-cCRs. The median time to TME for near-cCRs was 1 year.
3-year DFS was 88% for cCR, 69% for near-cCR, and 56% for incomplete response.
_____________________________
For patient counseling purposes:
Of the 123 patients with a cCR who were offered WW, the local recurrence rate was 22% (0f which 93% underwent salvage TME) and the rate of distant metastasis was 10.5%.
Of the 94 patients with a near-cCR who were offered WW, local recurrence rate was 51% (of which 71% underwent salvage TME) and the rate of distant metastasis was 15%.
Of the 57 patients with incomplete response who were offered upfront TME, local recurrence was 14% and the rate of distant metastasis was 32%.
@JohnRTMonsonMD@R_Perez_MD@ianmpaquette@JonVogel7@jendavidsmd@KyleCologne@debby_keller@juliomayol@Neil_J_Smart@FergaljFleming@ScottRSteeleMD@JISBMD
"Hartmann’s procedure no longer has a role in colorectal surgery" is way too strong of a hypothesis.
All retrospective data on HP vs protected anastomosis suffers from selection bias.
RCTs never worked due to low accrual, which is ALSO selection bias, although appropriate, ie decisions at 2am that "this one is too sick for the trial."
Astonishing that it's taken a TV programme to get the truth about #PostOfficeScandal out to most people. I heard more than 3 years ago when it had already been going on for 20 years. I hope we never see such a blatant miscarriage of justice again. Maybe social media will stop it?
A huge miscarriage of justice. Up to 960 postmasters were wrongly convicted of fraud, theft and false accounting but it later emerged that shortfalls in their accounts were the result of flaws in the Post Office Horizon IT system.
We got through about 10 minutes of #MrBatesVsThePostOffice and had to turn it off. An infuriating injustice, and we knew there would be no happy ending. Just awful.
Fascinating results from the EAGLE study, emphasizing the importance of quality improvement interventions in surgical procedures like right colectomy. Anastomotic leak remains a critical concern, and insights from such a widespread trial can be invaluable. For those seeking expansive explanations or related biomedical reviews, check out sciqst.com – a one-stop platform with AI capabilities to generate comprehensive biomedical literature reviews. It's a free resource that might offer deeper understanding of these findings. #Medicine#Surgery#Colectomy#QualityImprovement#Healthcare
More evidence that we have reached peak "surgical technique" + dogma.
We cannot improve the mechanics of anastomosis any further.
Time to focus on biology + patient factors.